临床药师参与1例亚急性心肌梗死合并腔隙性脑梗及深静脉血栓患者的抗栓治疗体会

杨贤; 郑萍

doi:10.3969/j.issn.1006-0111.2017.02.016

临床药师参与1例亚急性心肌梗死合并腔隙性脑梗及深静脉血栓患者的抗栓治疗体会

doi: 10.3969/j.issn.1006-0111.2017.02.016

杨贤¹,
郑萍^2,

1.
南京大学医学院附属鼓楼医院药学部, 江苏南京 210008
2.
广州南方医科大学南方医院药学部, 广东广州 510515

Clinical pharmacists participating in antithrombotic treatment in subacute myocardial infarction patient with cerebral lacuna infarction and deep vein thrombosis

YANG Xian¹,
ZHENG Ping^2
,

1.
Department of Pharmacy, Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing 210008, China
2.
Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China

摘要: 目的探讨亚急性心梗合并腔梗及深静脉血栓患者的抗栓策略，协助临床制订个体化的用药方案。方法临床药师通过分析血栓形成的原因，评估缺血及出血风险，查找循证医学证据，提出合理建议，并观察药物疗效、监护用药安全。结果患者存在多个血栓危险因素，同时属于出血很高危人群。药师建议阿司匹林剂量减少为75 mg，qd，加用质子泵抑制剂，同时联合低分子肝素抗凝。药师建议被部分采纳。患者病情好转后出院，且住院期间未出现出血及血栓症状。结论临床药师在协助医生积极抗栓的同时，最大程度地保证了用药安全。
- 亚急性心肌梗死 /
- 腔隙性脑梗死 /
- 深静脉血栓 /
- 抗栓治疗
Abstract: Objective To discuss antithrombotic drug treatment in subacute myocardial infarction patient with cerebral lacuna infarction and deep vein thrombosis. Methods Clinical pharmacists analyzed the causes of the blood clot formation, assessed ischemia and hemorrhage risk, consulted evidence-based medicine information, put forward reasonable suggestions and monitored the medication efficacy and safety. Results There were a lot of risk factors of thrombosis in this patient who was also at high risk of bleeding. Clinical pharmacists recommended to reduce aspirin dose to 75 mg daily and add proton pump inhibitors. Anticoagulant therapy should also include low molecular heparin. Some suggestions were accepted by doctors. The patient's condition was improved and there was no bleeding during hospitalization. Conclusion Clinical pharmacists assisted doctors in the antithrombotic treatment and maximized medication safety.
- subacute myocardial infarction /
- cerebral lacuna infarction /
- deep vein thrombosis /
- antithrombotic treatment

[1]	Ness J,Aronow WS. Prevalence of coronary artery disease,ischemic stroke,peripheral arterial disease,and coronary revascularization in older African-Americans,Asians,Hispanics,whites,men,and women[J].Am J Cardiol,1999,84(8):932-933.
[2]	朱敏林,梁丽珠,谢玉梅. 急性心肌梗死患者预防并发下肢深静脉血栓的护理方法[J].血栓与止血学,2015,21(3):187-189.
[3]	中华医学会心血管病学分会,中华心血管病杂志编辑委员会. 中国心血管病预防指南[J]. 中华心血管病杂志,2011,39(1):3-22.
[4]	Alan JG,Martin JA,Joshua IB,et al. Consensus statement by the american association of clinical endocrinologists and american college of endocrinology on the comprehensive type 2 diabetes management algorithm[J].Endocr Pract,2016,22(1):84-113.
[5]	Washam JB,Herzog CA,Beitelshees AL,et al. Pharmacotherapy in chronic kidney disease patients presenting with acute coronary syndrome:A scientific statement from the American Heart Association[J].Circulation,2015,131(12):1123-49.
[6]	廖敏辉,李平,刘永刚. GRACE与CRUSADE危险评分的相关性研究[J].中国药师,2015,18(3):441-443.
[7]	中华医学会心血管病学分会,中华心血管病杂志编辑委员会. 非ST段抬高急性冠状动脉综合征诊断和治疗指南[J]. 中华心血管病杂志,2012,40(5):353-367.
[8]	中华医学会心血管病学分会,中华心血管病杂志编辑委员会. 抗血小板治疗中国专家共识[J]. 中华心血管病杂志,2013,41(3):183-194.
[9]	抗栓治疗消化道损伤防治专家组. 抗栓治疗消化道损伤防治中国专家建议(2016)[J]. 中华内科杂志,2016,55(7):564-567.
[10]	中华医学会外科学分会,血管外科学组. 深静脉血栓形成的诊断和治疗指南[J]. 中华普通外科杂志,2012,50(7):611-614.
[11]	中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南(2014)[J]. 中华神经科杂志,2015,48(4):246-257.
[12]	中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国缺血性脑卒中和短暂性脑缺血发作二级预防指南[J]. 中华神经科杂志,2015,48(4):258-273.
[13]	脑小血管病诊治专家共识组. 中国脑小血管病诊治专家共识[J]. 中华内科杂志,2015,52(10):893-896.
[14]	中华医学会心血管病学分会,中国老年学学会心脑血管病专业委员会. 华法林抗凝治疗的中国专家共识[J]. 中华外科杂志,2012,52(1):76-82.
[15]	Kearon C,Akl EA,Comerota AJ,et al. Antithrombotic therapy for VTE disease:Antithrombotic therapy and prevention of thrombosis,9th ed:American college of chest physicians evidence-based clinical practice guidelines[J].Chest,2012,141(2 Suppl):e419S-e494S.

[1]	李锐, 张倩倩, 王瑞冬, 高小峰. 国家集中带量采购政策下样本医院良性前列腺增生治疗药物使用情况分析 . 药学实践与服务, 2025, 43(2): 1-6. doi: 10.12206/j.issn.2097-2024.202408031
[2]	王耀振, 徐灿, 吕顺莉, 田泾, 张东炜. 钾离子竞争性酸阻滞剂的药学特征研究进展 . 药学实践与服务, 2024, 42(7): 278-284. doi: 10.12206/j.issn.2097-2024.202306040
[3]	陈静, 何瑞华, 翁月, 徐熠, 刘静, 黄瑾. 基于网络药理学和分子对接技术探究定清片活性成分治疗白血病的作用机制 . 药学实践与服务, 2024, 42(11): 479-486. doi: 10.12206/j.issn.2097-2024.202401073
[4]	陈金涛, 乔子婴, 马明华, 张若曦, 王振伟, 年华. 基于网络药理学和分子对接技术研究金芪清疏颗粒治疗社区获得性肺炎的潜在机制 . 药学实践与服务, 2024, 42(11): 471-478. doi: 10.12206/j.issn.2097-2024.202312014
[5]	宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅. 帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
[6]	徐璐璐, 刘爱军. 丹参白术方“异病同治”冠心病、血管性痴呆、特发性膜性肾病的网络药理学作用机制研究 . 药学实践与服务, 2024, 42(12): 1-8. doi: 10.12206/j.issn.2097-2024.202312027
[7]	张艺昕, 关欣怡, 王博宁, 闻俊, 洪战英. 二氢吡啶类钙离子拮抗药物手性分析及其立体选择性药动学研究进展 . 药学实践与服务, 2024, 42(8): 319-324. doi: 10.12206/j.issn.2097-2024.202308062
[8]	陈春娟, 郑志新, 李骊. 平喘方联合孟鲁司特钠治疗儿童支气管哮喘患者的临床疗效观察 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202405035
[9]	景凯, 杨慈荣, 张圳, 臧艺蓓, 刘霞. 黄芪甲苷衍生物治疗慢性心力衰竭小鼠的药效评价及作用机制研究 . 药学实践与服务, 2024, 42(5): 190-197. doi: 10.12206/j.issn.2097-2024.202310004
[10]	陈莹, 许子华, 胡北, 崔亚玲, 高欢, 吴琼. 通便灵胶囊治疗便秘的药效与机制研究 . 药学实践与服务, 2024, 42(): 1-7. doi: 10.12206/j.issn.2097-2024.202404008
[11]	马兹芬, 许维恒, 金煜翔, 薛磊. 食管癌的靶向治疗与免疫治疗研究进展 . 药学实践与服务, 2024, 42(6): 231-237. doi: 10.12206/j.issn.2097-2024.202306008
[12]	宋泽成, 陈林林, 鲁仁义, 刘梦肖, 王彦. 脓毒症治疗的研究进展 . 药学实践与服务, 2024, 42(11): 457-460, 502. doi: 10.12206/j.issn.2097-2024.202405059
[13]	郭灵怡, 刘艳超, 高路, 刘瑞瑶, 吕权真, 俞媛. 醋酸卡泊芬净单硬脂酸甘油酯纳米粒抗白色念珠菌感染的增效作用研究 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202310043
[14]	迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛. 负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架用于创伤性脑损伤治疗 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202406034
[15]	唐淑慧, 凤美娟, 薛智霞, 鲁桂华. 帕博利珠单抗治疗所致免疫相关不良反应与中医体质的相关性研究 . 药学实践与服务, 2024, 42(5): 217-222. doi: 10.12206/j.issn.2097-2024.202311029
[16]	刘丽艳, 余小翠, 孙传铎. 纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(10): 451-456. doi: 10.12206/j.issn.2097-2024.202310044
[17]	石晓萍, 吕迁洲, 李晓宇, 许青. 泊沙康唑对比伏立康唑经验治疗或诊断驱动治疗免疫功能低下患者侵袭性霉菌病的成本-效果分析 . 药学实践与服务, 2024, 42(): 1-8. doi: 10.12206/j.issn.2097-2024.202401050
[18]	孙丹倪, 黄勇, 张嘉宝, 王培. 代谢相关脂肪性肝病的无创诊断与药物治疗 . 药学实践与服务, 2024, 42(10): 411-418. doi: 10.12206/j.issn.2097-2024.202403049
[19]	张晶晶, 索丽娜, 郑兆红. 89例细菌性肝脓肿的临床特征及抗感染治疗分析 . 药学实践与服务, 2024, 42(6): 267-272. doi: 10.12206/j.issn.2097-2024.202302039
[20]	丁华敏, 郭羽晨, 秦春霞, 宋志兵, 孙莉莉. 消风止痒颗粒通过降低白三烯水平对小鼠特应性皮炎急性瘙痒的治疗作用研究 . 药学实践与服务, 2024, 42(5): 211-216. doi: 10.12206/j.issn.2097-2024.202306031

点击查看大图

计量

文章访问数: 3065
HTML全文浏览量: 348
PDF下载量: 379
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

临床药师参与1例亚急性心肌梗死合并腔隙性脑梗及深静脉血栓患者的抗栓治疗体会

doi: 10.3969/j.issn.1006-0111.2017.02.016

Clinical pharmacists participating in antithrombotic treatment in subacute myocardial infarction patient with cerebral lacuna infarction and deep vein thrombosis

计量

临床药师参与1例亚急性心肌梗死合并腔隙性脑梗及深静脉血栓患者的抗栓治疗体会

doi: 10.3969/j.issn.1006-0111.2017.02.016

1. 南京大学医学院附属鼓楼医院药学部, 江苏南京 210008

2. 广州南方医科大学南方医院药学部, 广东广州 510515

English Abstract

Clinical pharmacists participating in antithrombotic treatment in subacute myocardial infarction patient with cerebral lacuna infarction and deep vein thrombosis

1. Department of Pharmacy, Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing 210008, China

2. Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China

全文HTML

目录

留言板

临床药师参与1例亚急性心肌梗死合并腔隙性脑梗及深静脉血栓患者的抗栓治疗体会

doi: 10.3969/j.issn.1006-0111.2017.02.016

Clinical pharmacists participating in antithrombotic treatment in subacute myocardial infarction patient with cerebral lacuna infarction and deep vein thrombosis

计量

出版历程

临床药师参与1例亚急性心肌梗死合并腔隙性脑梗及深静脉血栓患者的抗栓治疗体会

doi: 10.3969/j.issn.1006-0111.2017.02.016

1. 南京大学医学院附属鼓楼医院药学部, 江苏 南京 210008 2. 广州南方医科大学南方医院药学部, 广东 广州 510515

English Abstract

Clinical pharmacists participating in antithrombotic treatment in subacute myocardial infarction patient with cerebral lacuna infarction and deep vein thrombosis

1. Department of Pharmacy, Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing 210008, China 2. Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China

全文HTML

目录

1. 南京大学医学院附属鼓楼医院药学部, 江苏南京 210008

2. 广州南方医科大学南方医院药学部, 广东广州 510515

1. Department of Pharmacy, Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing 210008, China

2. Department of Pharmacy, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China